Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Elan to market Dainippon's zonisamide in North America

May 15, 1997

Glutamate antagonists from Warner-Lambert

May 15, 1997

MS&D discloses 5-HT1-like receptor agonists

May 15, 1997

MS&D describes tachykinin antagonists

May 15, 1997

ET antagonists from Warner-Lambert claimed for cerebrovascular disorders

May 15, 1997

CollaGenex promotes Ponstel for short-term dental pain relief

May 14, 1997

New antimigraine agents from Merck Sharp & Dohme

May 14, 1997

Forest submits NDA for antidepressant

May 13, 1997

CRF receptor antagonist from Pfizer active in animal model of depression

May 13, 1997

FDA advisory committee votes against Myotrophin approval

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...